CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-04 | Dethlefs Sven EVP Global Marketing&Portfolio | Sale | −6,012 | $10.57 | $64K | 77,975.7 |
| 2021-03-04 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise · Restricted Share Units | −13,930 | 27,861 | ||
| 2021-03-04 | Daniell Richard Exec. VP, European Commercial | Option exercise | +15,920 | 27,793 | ||
| 2021-03-04 | Daniell Richard Exec. VP, European Commercial | Sale | −7,513 | $10.58 | $80K | 20,280 |
| 2021-03-04 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −15,920 | 31,841 | ||
| 2021-03-03 | O'Grady Brendan P. EVP, North America Commercial | Option exercise | +1,166 | 16,034.49 | ||
| 2021-03-03 | O'Grady Brendan P. EVP, North America Commercial | Sale | −463 | $10.86 | $5K | 15,571.49 |
| 2021-03-03 | O'Grady Brendan P. EVP, North America Commercial | Option exercise · Restricted Share Units | −1,166 | 0 | ||
| 2021-03-03 | Nazzi Gianfranco EVP, International Markets | Option exercise | +1,400 | 1,400 | ||
| 2021-03-03 | Nazzi Gianfranco EVP, International Markets | Sale | −1,400 | $10.88 | $15K | 0 |
| 2021-03-03 | Nazzi Gianfranco EVP, International Markets | Option exercise · Restricted Share Units | −1,400 | 0 | ||
| 2021-03-03 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise | +1,400 | 70,663.7 | ||
| 2021-03-03 | Dethlefs Sven EVP Global Marketing&Portfolio | Sale | −606 | $10.86 | $7K | 70,057.7 |
| 2021-03-03 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise · Restricted Share Units | −1,400 | 0 | ||
| 2021-03-03 | Daniell Richard Exec. VP, European Commercial | Option exercise | +2,101 | 12,866 | ||
| 2021-03-03 | Daniell Richard Exec. VP, European Commercial | Sale | −993 | $10.88 | $11K | 11,873 |
| 2021-03-03 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −2,101 | 0 | ||
| 2021-03-02 | O'Grady Brendan P. EVP, North America Commercial | Sale | −15,085 | $10.85 | $164K | 14,868.49 |
| 2021-03-02 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −50,000 | $10.82 | $541K | 64,063.51 |
| 2021-03-01 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −18,430 | $10.83 | $200K | 2,974.39 |
Page 48 of 76 · 1,517 trades